COMMUNIQUÉS West-GlobeNewswire

Microbot Medical Announces Outcome of Annual Meeting of Shareholders
13/09/2019
Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM ) HINGHAM, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Having successfully executed a number of significant milestones over the past twelve [...]
Adamas Pharmaceuticals Appoints Neil McFarlane as Chief Executive Officer
13/09/2019
- Gregory Went, Ph.D., Founder, transitions to a strategic advisory role - David Mahoney, lead independent director, appointed to Chairman of the Board EMERYVILLE, Calif., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Adamas [...]
Helius Medical Technologies, Inc. Announces Addition of a New PoNS™ Clinic in Quebec City, Canada
13/09/2019
NEWTOWN, Pa., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that Clinique [...]
Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the Heart Failure Society of America (HFSA) 23rd Annual Scientific Meeting
13/09/2019
NEW YORK, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in [...]
Vectura provides update on GSK Litigation
13/09/2019
Vectura provides update on GSK Litigation Chippenham, UK – 13 September 2019 : Vectura Group plc (LSE: VEC) ("Vectura" or "the Group") announces that following the award of US$89.7m in damages to Vectura by a jury in [...]
Orchard Therapeutics Announces Departure of Chief Commercial Officer
13/09/2019
BOSTON and LONDON, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
Teleflex to Support Responding to Cardiac Arrest at ERC Congress 2019, in Ljubljana, Slovenia from September 19th – 21st
13/09/2019
WAYNE, Pa., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, will focus on its Arrow® EZ-IO® Intraosseous Access System and on the campaigns “What [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
13/09/2019
Company announcement – No. 34/ 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 13, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 [...]
Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019
13/09/2019
Enrollment in the fourth and final planned Phase 1 dose escalation cohort completed ATA188 targets Epstein-Barr Virus (EBV)-infected B cells, believed to play a role in the pathogenesis of multiple sclerosis Conference [...]
Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock
13/09/2019
CORAL GABLES, Fla., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) today announced that it will not conclude the offering of shares of its common stock announced on Wednesday, [...]
Digirad Announces Listing and Trading of Preferred Stock on Nasdaq Global Market Under Symbol “DRADP”
13/09/2019
SUWANEE, Ga., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “Company”) announced that its newly issued 10.0% Series A Cumulative Perpetual Preferred Stock, with a stated value [...]
Change of Chairman at ALK
13/09/2019
ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that Steen Riisgaard, ALK’s Chairman of the Board, has informed the Board of Directors of his intention to step down at the company's next Annual General [...]
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
13/09/2019
Post-hoc analysis from a Phase III open-label extension study showed a 42 percent reduction in the risk of PPMS patients needing a wheelchair after 6.5 years of OCREVUS treatment compared with patients who started [...]
Innate Pharma reports first half 2019 financial results and business update
13/09/2019
INNATE PHARMA REPORTS FIRST HALF 2019 FINANCIAL RESULTS AND BUSINESS UPDATE Initiation of multi-cohort IPH4102 Phase II clinical trial (TELLOMAK) Sézary Syndrome cohort designed to be pivotal; preclinical data supports [...]
Innate Pharma présente ses résultats financiers et l’avancée de son portefeuille au premier semestre 2019
13/09/2019
INNATE PHARMA PRÉSENTE SES RÉSULTATS FINANCIERS ET L’AVANCÉE DE SON PORTEFEUILLE AU PREMIER SEMESTRE 2019 Démarrage de l’essai clinique multicohorte de Phase II d’IPH4102 (TELLOMAK) ; La cohorte syndrome de Sézary est [...]
Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer
13/09/2019
New fixed-dose combination is administered under the skin in just minutes, significantly reducing the time spent receiving treatment Data will be submitted to health authorities around the world, including the US Food [...]
SpringWorks Therapeutics Announces Pricing Of Initial Public Offering
13/09/2019
STAMFORD, Conn., Sept. 12, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and [...]
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell
12/09/2019
- Total consideration of $ 63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals [...]
NOTICE TO DISREGARD – Progressive Care Inc.
12/09/2019
MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- We are advised by Progressive Care, Inc. that journalists and other readers should disregard the news release, Progressive Care Inc. Subsidiaries PharmCo and Family Physicians [...]

Pages